Abstract:Background: Hepatocellular carcinoma (HCC) represents the predominant and most fatal malignancy globally. The primary therapeutic approach for HCC is Hepatectomy, which presents a potential for curative outcomes. This analysis aims to offer an exhaustive examination of the clinical repercussions linked to liver resection or Hepatectomy in HCC, underscore recent advancements in surgical methodologies, and deliberate on future pathways to enhance treatment efficacy in this domain. Methods: A thorough exploration of the literature was carried out across prominent databases, including Google Scholar, PubMed, ScienceDirect, and Cochrane Library. Research articles were chosen based on their pertinence to the outcomes of Hepatectomy in HCC, advancements in surgical techniques, and forthcoming therapeutic schemes to scrutinize the short- and long-term clinical consequences and the variables influencing these outcomes. Results: Hepatectomy for HCC manifests notable diversity in clinical outcomes, impacted by the nature of the tumor, characteristics of the patient cohort, and proficiency of the surgical team. Short-term results, like perioperative morbidity and mortality rates, have demonstrated enhancements in tandem with refinements in preoperative evaluations and intraoperative management. The duration of outcomes, encompassing overall survival and disease-free survival, displayed significant associations with extended resections, tumor characteristics, and postoperative assessments. Recent progressions in Hepatectomy have played a role in diminishing perioperative complications and expediting the recovery process. Furthermore, the amalgamation of adjuvant and neoadjuvant therapies, alongside the emergence of pharmaceutical modalities, can elevate survival rates and enhance the quality of life for individuals with HCC. Conclusion: Hepatectomy emerges as a pivotal intervention for HCC, yielding progressively superior outcomes owing to technological advancements and enhanced perioperative care. Prospective investigations will refine surgical techniques, optimize adjuvant therapies, and formulate robust predictive frameworks for diverse therapeutic modalities. This comprehensive assessment accentuates the significance of sustained innovation and interdisciplinary cooperation to elevate the standard of care for HCC patients. Moreover, continuous investigation into adjuvant and neoadjuvant treatments, such as immunotherapy and targeted therapies, is imperative for enhancing long-term prognoses.

Analysis of Survival Rate and Influencing Factors in Surgical Treatment of Primary Hepatocellular Carcinoma

Retrospective Analysis on 682 Cases of Liver Cancer after Surgical Treatment

Surgical Treatment of Primary Hepatoeellular Carcinoma: a 20-Year Clinical Experience in 7566 Patients

Progress in Surgical Procedures of Hepatocellular Carcinoma

Analysis of the Risk Factors Influencing the Prognosis of Orthotopic Liver Transplantation for Hepatocellular Carcinoma and Summary of Relevant Clinical Experience

[Prognostic Factors Influencing Postoperative Survival in Patients with </= 3 Cm Small Hepatocellular Carcinoma].

Advancements in the Surgical Treatment of Hepatocellular Carcinoma

Survival Factors after Resection of Small Hepatocellular Carcinoma.

Preoperative CT analysis of multi-factors influencing the prognosis of patients with primary hepatocellular carcinoma after radical hepatectomy

[Surgical Treatment of 1450 Patients with Hepatocellular Carcinoma].

Surgical Treatment of Hepatocellular Carcinoma and Related Basic Research with Special Reference to Recurrence and Metastasis

Evaluation of the effectiveness of surgical resection and ablation for the treatment of early-stage hepatocellular carcinoma: A retrospective cohort study

Influencing Factors for Prognosis of Patients with Hepatocellular Carcinoma Complicated with Portal Vein Tumor Thrombus after Surgical Treatment

[Time Dependency of Factors Influencing Survival of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis after Surgery].

Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study

Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors

Recent Advances, Future Directions and Clinical Outcomes of Hepatectomy in Hepatocellular Carcinoma

Progress and Prospects in Hepatocellular Carcinoma Surgery.

Prognosis risk factors and therapeutic effect analysis in primary hepatic carcinoma: 394 cases report

Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma

[Liver Transplantation for Hepatocellular Carcinoma: Prognostic Analysis of 89 Cases].